Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Cash | 2.270 | 7.510 | 5.240 |
| Shares | 97.330 | 97.330 | 0.000 |
| Bonds | 0.300 | 0.300 | 0.000 |
| Convertible | 0.090 | 0.090 | 0.000 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 17.639 | 19.267 |
| Price to Book | 2.799 | 3.800 |
| Price to Sales | 1.830 | 2.185 |
| Price to Cash Flow | 7.919 | 14.309 |
| Dividend Yield | 0.590 | 1.474 |
| 5 Years Earnings Growth | 14.009 | 9.938 |
Number of long holdings: 33
Number of short holdings: 1
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| UCB | BE0003739530 | 9.66 | 240.50 | +0.84% | |
| Northern Trust Global US Dollar F | IE00B235DM89 | 7.77 | - | - | |
| Argen-X | NL0010832176 | 6.00 | 782.40 | -1.06% | |
| Zealand Pharma | DK0060257814 | 5.33 | 516.40 | -1.75% | |
| Fresenius SE | DE0005785604 | 4.97 | 47.330 | -0.06% | |
| H Lundbeck B | DK0061804770 | 4.16 | 44.42 | +0.82% | |
| Boston Scientific | US1011371077 | 3.61 | 101.58 | +0.61% | |
| Ascendis Pharma AS | US04351P1012 | 3.59 | 212.33 | +1.10% | |
| Uniphar | IE00BJ5FQX74 | 3.39 | 3.77 | +1.34% | |
| Innovent Biologics | KYG4818G1010 | 3.38 | 94.10 | -2.18% |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Global Technology Fund I E | 10.2B | 59.93 | 46.22 | 23.23 | ||
| Global Technology Fund RE | 10.2B | 59.26 | 45.48 | 22.70 | ||
| Global Technology FunD E | 10.2B | 17.39 | 29.43 | 19.08 | ||
| IE00BTN23623 | 10.2B | 2.01 | 16.50 | 14.75 | ||
| IE00BZ4D7648 | 10.2B | 2.04 | 16.56 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review